BRCA2 and hereditary breast ovarian cancer syndrome: It involved 95 individuals who had a clinical suspicion of HBOC syndrome, and criteria for genetic risk evaluation according to the NCCN Clinical Practice Guidelines in Oncology, and a cumulative risk of BRCA1 and BRCA2 variants higher than 10%, using PennII model, in addition to a personal history of cancer.